The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

Canavan Disease

Prevalence: 1/100000
lysosomal

Aspartoacylase deficiency and white matter degeneration due to ASPA gene mutations.